Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on May 12, 2025
BridgeBio to Present Clinical Outcomes, Quality of Life Measures and Incidence of Atrial Fibrillation Events in Patients with ATTR-CM from the ATTRibute-CM Study at the Annual Congress of the Heart Failure Association of the ESC
GlobeNewswire
·
May 12, 2025
PALO ALTO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that one rapid-fire abstract and two moderated …
Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million
GlobeNewswire
·
May 12, 2025
CLEVELAND, May 12, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $155 …
Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance
GlobeNewswire
·
May 12, 2025
BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. …
Solo Brands, Inc. Announces First Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
GRAPEVINE, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Solo Brands, Inc. (NYSE: DTC; OTC: DTCB)(1) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel …
Invivyd Announces New Pipeline Discovery Program Focused on Monoclonal Antibody Treatment for Measles
GlobeNewswire
·
May 12, 2025
Multiple HCPs have requested from Invivyd a monoclonal antibody (mAb) for treatment of active measles infection and post-exposure prophylaxis to reduce the consequence of outbreaks. Such a medicine could accelerate the pathway to functional eradication of …
Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
GlobeNewswire
·
May 12, 2025
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in mid-2025 MET-233i, a monthly, ultra-long acting amylin analog, is in Phase 1 trials as a …
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
May 12, 2025
Announced positive interim data for LX2006 from Phase 1/2 studies in Friederich ataxia (FA) cardiomyopathy; frataxin expression and LVMI improvement exceeded co-primary target thresholds for planned registrational study LX2006 registrational study expected …
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
GlobeNewswire
·
May 12, 2025
Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Cash on hand of approximately $125 million as of March 31, 2025 expected to provide runway …
Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 12, 2025
– Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 – – Combination trial of TNG462 + Revolution Medicines RAS(ON) inhibitors on track for enrollment 2Q 2025 – – Cash position of $217 million as of March 31, 2025; cash runway …
Harvard Bioscience Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
HOLLISTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2025. Jim Green, Chairman and CEO, said, “First quarter revenues were in line …
Sionna Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
Phase 1 dosing completed for NBD1 stabilizers SION-719 & SION-451; both compounds continue to be generally well tolerated Phase 1 topline data anticipated this quarter On track to initiate Phase 2a proof-of-concept trial and at least one dual combination …
Advantage Solutions Reports First Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
Supporting clients through a challenging operating environment Continuing to make progress on transformation initiatives that will streamline operations Management lowers guidance to reflect heightened market uncertainty ST. LOUIS, May 12, 2025 (GLOBE …
Lightbridge Provides Business Update and Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 12, 2025
RESTON, Va., May 12, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the first quarter ended March 31, 2025, and provided an …
Akero Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Phase 2b SYMMETRY study preliminary results showed statistically significant reversal of compensated cirrhosis (F4) due to MASH following 96 weeks of treatment with efruxifermin (EFX) Presented two oral presentations and a poster presentation highlighting …
Aya Gold & Silver Secures US$25 Million Credit Facility from EBRD to Support Growth in Morocco
GlobeNewswire
·
May 12, 2025
MONTREAL, May 12, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce that it has received final internal approval by the Board of Directors of the European Bank for Reconstruction …
Wag! Reports First Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co. (the “Company” or “Wag!”; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced financial …
Macerich Reports First Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
SANTA MONICA, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has released its First Quarter 2025 Earnings Results and Supplemental Information by posting it to the Investor Relations section of its website at investing.macerich. …
BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 12, 2025
Enrollment complete in SERENITY At-Home pivotal Phase 3 safety trial for acute treatment of agitation associated with bipolar disorders or schizophrenia Topline data expected in second half of 2025 intended to support potential sNDA submission for label …
Precore Gold Announces Nomination of Louis Gariepy to Its Board of Directors, Completion of the Arikepay Agreement and Granting of Stock Options
GlobeNewswire
·
May 12, 2025
VANCOUVER, British Columbia, May 12, 2025 (GLOBE NEWSWIRE) -- Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce the nomination of Mr. Louis Gariepy, P. Eng (OIQ) for election to its Board of Directors at the Company's …
Blade Air Mobility Announces First Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
Net loss improved by $0.7 million versus the prior year to $(3.5) million in Q1 2025; Adjusted EBITDA improved by $2.3 million versus the prior year to $(1.2) million in Q1 2025(1) First Adjusted EBITDA profitable Q1 in the Passenger Segment since going …